ERBB2 and cancer: Although we could not identify distinct marker genes specific to a subtype for fibroblasts, endothelial cells, or macrophages in the HR-positive and HER2-positive subtypes, it is evident that the cell types constituting the TME in cancer patients exhibit entirely different gene expression patterns when compared to those in normal tissue.